System Physiology – Animal Short Notes
One-page CSIR NET revision for Unit 7: blood, heart, lungs, kidney, acid-base, nerves, senses, digestion, temperature, hormones, reproduction and microbiome.
- 14 min
On this page · 10 sections
The whole of Unit 7 on one page. For explanations and worked problems, go back to the chapter: Blood and Cardiovascular System, Respiratory and Renal Physiology, Nervous System and Sense Organs, Digestion, Energy Balance and Thermoregulation, Endocrinology and Reproduction and Gut Microbiome and Interorgan Communication.
Blood and Haemostasis
| Fact | Detail |
|---|---|
| Composition | Plasma about 55%; haematocrit about 42% (men), 38% (women) |
| Plasma vs serum | Serum lacks fibrinogen and consumed clotting factors |
| Albumin | Main source of plasma oncotic pressure; carries bilirubin, fatty acids |
| RBC | About 5 million/µL; 120-day life; glycolysis only; 2,3-BPG shunt |
| Leucocyte order | Neutrophils > lymphocytes > monocytes > eosinophils > basophils |
| Platelets | 1.5–4 lakh/µL; 7–10 days; from megakaryocytes (TPO) |
| Haemopoiesis sites | Yolk sac → liver/spleen → bone marrow |
| EPO | Kidney peritubular interstitial cells; hypoxia → HIF |
| Anaemias | Iron: microcytic hypochromic; B₁₂/folate: megaloblastic; CKD: low EPO |
| Bilirubin | Haem → biliverdin → bilirubin → UDP-glucuronosyltransferase (liver) → stercobilin |
| ABO | A adds GalNAc, B adds galactose to H; Iᴬ, Iᴮ codominant; natural IgM anti-A/B |
| Donors | O red cells universal donor; AB universal recipient; AB plasma universal |
| Bombay (hh) | No H; anti-H + anti-A + anti-B; types as O |
| Rh | Anti-D is IgG, appears after sensitisation; HDFN in later pregnancy; anti-D prophylaxis |
| Platelet plug | vWF–GPIb adhesion; ADP, TXA₂; GPIIb/IIIa–fibrinogen aggregation |
| Extrinsic | TF + VIIa → X |
| Intrinsic | XII → XI → IX (+ VIIIa) → X |
| Common | Xa + Va → thrombin → fibrin; XIIIa cross-links (transglutaminase) |
| Vitamin K | γ-carboxylation of II, VII, IX, X, C, S; warfarin blocks epoxide reductase |
| Brakes | Antithrombin (heparin), protein C + S, TFPI, plasmin (tPA) → D-dimers |
| PT / aPTT | PT extrinsic, warfarin; aPTT intrinsic, heparin, haemophilia |
| Haemophilia | A = VIII, B = IX; X-linked recessive |
| Lab anticoagulants | Citrate, oxalate, EDTA chelate Ca²⁺; heparin |
Heart and Circulation
| Fact | Detail |
|---|---|
| Conduction | SA → atria → AV (delay about 0.1 s) → His → bundle branches → Purkinje |
| Pacemaker rates | SA 70–80, AV 40–60, Purkinje 15–40 per min; SA intrinsic rate after full autonomic block about 100/min (vagal tone slows it at rest) |
| SA node | Phase 4 I_f (HCN) + T-type Ca²⁺; upstroke L-type Ca²⁺ |
| Ventricle | Phase 0 fast Na⁺; 1 I_to; 2 plateau L-type Ca²⁺; 3 delayed rectifier K⁺; 4 I_K1 at about −90 mV |
| No tetanus | Long refractory period from the plateau |
| Sympathetic / vagal | β₁ → cAMP → ↑ I_f, I_Ca; M₂ → GIRK → slower |
| E–C coupling | L-type Ca²⁺ → RyR2 (Ca²⁺-induced Ca²⁺ release); SERCA + phospholamban; NCX |
| Digoxin | Na⁺/K⁺-ATPase inhibition → ↑ Ca²⁺ → positive inotropy |
| ECG | P atrial depolarisation; PR 0.12–0.20 s; QRS under 0.12 s; T ventricular repolarisation |
| ECG paper | 25 mm/s; small square 0.04 s; large 0.2 s; rate = 1500/small = 300/large |
| Einthoven | II = I + III |
| Blocks | 1st: PR over 0.2 s; Mobitz I: progressive PR; 3rd: P and QRS dissociated |
| Hyperkalaemia | Tall peaked T |
| Cycle | 0.8 s at 75/min; two isovolumetric phases with all valves closed |
| Heart sounds | S1 AV closure; S2 semilunar closure; S3 rapid filling; S4 atrial kick into stiff ventricle |
| LV numbers | EDV 120–130, ESV 50–60, SV about 70 mL; EF 55–60% |
| CO | HR × SV ≈ 5 L/min; Fick: VO₂/(CaO₂ − CvO₂) |
| Frank–Starling | More stretch → stronger contraction |
| Poiseuille | R = 8ηL/πr⁴; halve radius → 16× resistance |
| Vessels | Arterioles: resistance; capillaries: largest area, slowest flow; veins: about two-thirds of volume |
| Starling forces | Jv = Kf[(Pc − Pi) − σ(πc − πi)] |
| MAP | DBP + PP/3; = CO × TPR |
| Baroreflex | Carotid sinus (IX), aortic arch (X) → NTS → ↓ sympathetic, ↑ vagal |
| RAAS | Renin (JG cells) → Ang I → ACE (lung) → Ang II: constriction, aldosterone, ADH, thirst |
| ANP / BNP | Atria / ventricles; cGMP; natriuresis |
| Long term | Pressure natriuresis |
| Hypoxia | Dilates systemic, constricts pulmonary arterioles |
Respiration
| Fact | Detail |
|---|---|
| Surfactant | DPPC + SP-A to D; type II cells; P = 2T/r; deficiency → neonatal RDS |
| Volumes (mL) | TV 500, IRV 3,000, ERV 1,100, RV 1,200 |
| Capacities | FRC 2,300, VC 4,600, TLC 5,800; RV not by spirometry |
| FEV₁/FVC | About 0.8; low in obstruction |
| Dead space | About 150 mL; Bohr: VD/VT = (PaCO₂ − PECO₂)/PaCO₂ |
| Alveolar ventilation | (VT − VD) × f |
| Alveolar gas equation | PAO₂ = 0.21(PB − 47) − PaCO₂/0.8 ≈ 100 mmHg |
| Blood gases | Arterial PO₂ about 95, PCO₂ 40; venous PO₂ 40, PCO₂ 46 |
| Diffusion | CO₂ about 20× faster than O₂; CO for DLCO |
| V/Q | About 0.8; apex high; shunt = 0, dead space = ∞ |
| O₂ content | 1.34 × Hb × SaO₂ + 0.003 × PaO₂ ≈ 20 mL/dL |
| P₅₀ | About 26–27 mmHg |
| Right shift | ↑ CO₂, H⁺, temperature, 2,3-BPG |
| Left shift | HbF (weak 2,3-BPG binding), CO, alkalosis, cold |
| CO | Affinity about 200–250× O₂; PaO₂ can be normal |
| CO₂ transport | HCO₃⁻ about 70%, carbamino about 20–23%, dissolved about 7–10% |
| Chloride shift | Band 3 (AE1) |
| Bohr vs Haldane | CO₂/H⁺ on O₂ binding vs O₂ on CO₂ binding |
| Rhythm | Pre-Bötzinger complex; DRG inspiratory; pontine group limits inspiration |
| Central chemoreceptors | CSF H⁺ from CO₂; main minute-to-minute drive |
| Peripheral chemoreceptors | Carotid (IX) and aortic (X) bodies; only sensors of low PaO₂ (below about 60 mmHg) |
| Hering–Breuer | Stretch receptors, vagus, end inspiration |
| Altitude | Hyperventilation → respiratory alkalosis → renal HCO₃⁻ loss; 2,3-BPG, EPO up; acetazolamide helps |
Kidney and Acid–Base
| Fact | Detail |
|---|---|
| Flows | RBF about 1.1–1.2 L/min; RPF 600–650 mL/min; GFR 125 mL/min (180 L/day); FF 0.2 |
| Filtration barrier | Fenestrated endothelium, negatively charged GBM, podocyte slit (nephrin) |
| GFR equation | Kf[(PGC − PBS) − πGC]; net about 10 mmHg |
| Efferent constriction | ↑ GFR, ↑ FF |
| Autoregulation | Myogenic + tubuloglomerular feedback (macula densa, adenosine); about 80–180 mmHg |
| Clearance | C = UV/P; inulin = GFR; PAH = RPF; RBF = RPF/(1 − Hct) |
| Glucose | SGLT2/SGLT1; Tm about 375 mg/min; threshold about 180–200 mg/dL; splay |
| PCT | 65% Na⁺ and water; NHE3; all glucose, amino acids; most HCO₃⁻; secretes PAH, drugs; NH₄⁺ from glutamine |
| Descending limb | Water-permeable (AQP1) |
| Thick ascending limb | NKCC2; water-impermeable; dilutes to about 100 mOsm/kg; furosemide |
| DCT | NCC; thiazides; PTH-regulated Ca²⁺ reabsorption |
| Principal cells | ENaC, ROMK; aldosterone; AQP2 via ADH-V₂-cAMP |
| Intercalated cells | Type A H⁺ secretion; type B HCO₃⁻ secretion (pendrin) |
| Concentration | Countercurrent multiplier, vasa recta exchanger, urea recycling; up to about 1,200 mOsm/kg |
| Free water | C_H₂O = V − C_osm; positive = dilute |
| Obligatory volume | 600 mOsm/day ÷ 1,200 mOsm/kg ≈ 0.5 L/day |
| ADH control | Osmoreceptors (1–2% change); volume (about 10% change) overrides |
| DI | Central: responds to desmopressin; nephrogenic: does not |
| SIADH | Concentrated urine, low plasma Na⁺ |
| Diuretics | Acetazolamide (CA), mannitol, loop (NKCC2), thiazide (NCC), amiloride (ENaC), spironolactone (MR) |
| Ca²⁺ and diuretics | Loop ↑ Ca²⁺ excretion; thiazide ↓ |
| Henderson–Hasselbalch | pH = 6.1 + log[HCO₃⁻/(0.03 × PCO₂)]; 24/1.2 = 20 → 7.40 |
| Renal acid excretion | Reclaim HCO₃⁻; new HCO₃⁻ via titratable acid (phosphate) and NH₄⁺ |
| ROME | Respiratory opposite, metabolic equal |
| Anion gap | Na⁺ − (Cl⁻ + HCO₃⁻); about 8–12 mM |
| High gap | Ketoacids, lactate, methanol, ethylene glycol, salicylate, uraemia |
| Normal gap | Diarrhoea, RTA, acetazolamide |
| Winter’s formula | Expected PCO₂ = 1.5 HCO₃⁻ + 8 ± 2 |
Nerves, Muscle Tone and Posture
| Fact | Detail |
|---|---|
| Nernst (37 °C) | E = (61.5/z) log(Co/Ci); E_K about −95, E_Na about +61, E_Cl about −64 mV |
| Goldman | Weights ions by permeability; Cl⁻ inside in numerator |
| Resting potential | About −70 mV; K⁺ leak; pump contributes a few mV |
| AP | Threshold about −55; Nav activation, inactivation (IFM motif); delayed-rectifier K⁺ |
| Refractory | Absolute (Nav inactivated), relative |
| Toxins | TTX, saxitoxin (Nav outside); lidocaine (inside); TEA (K⁺); ouabain (pump) |
| Hodgkin–Huxley | Squid giant axon, voltage clamp; published 1952 |
| Conduction | Myelinated ∝ diameter (saltatory); unmyelinated ∝ √diameter |
| Fibres | Aα 70–120 m/s; C 0.5–2 m/s unmyelinated; local anaesthetic blocks C first |
| Release | Ca²⁺ → synaptotagmin → SNAREs (VAMP, syntaxin, SNAP-25) |
| Toxins at synapse | Botulinum: flaccid; tetanus: spastic |
| NMDA | Ca²⁺-permeable, Mg²⁺ block, glycine co-agonist; LTP |
| GABA_A / glycine | Cl⁻ channels; benzodiazepines / strychnine |
| Glia | Oligodendrocytes (CNS, many axons); Schwann (PNS, one internode) |
| Tracts | Dorsal column crosses medulla; spinothalamic crosses cord; corticospinal crosses pyramids |
| Brown-Séquard | Ipsilateral motor + fine touch loss; contralateral pain + temperature loss |
| Sympathetic | T1–L2; short preganglionic; NA (sweat glands ACh); adrenal medulla |
| Parasympathetic | III, VII, IX, X, S2–S4; long preganglionic; ACh muscarinic |
| CSF | Choroid plexus; about 500 mL/day, about 150 mL present |
| Spindle | Parallel; length; Ia + II; γ motor; stretch reflex (monosynaptic) |
| Tendon organ | Series; tension; Ib; autogenic inhibition |
| Tone | γ loop; abolished by cutting dorsal roots |
| Size principle | Small motor units recruited first |
| Decerebrate rigidity | Intercollicular cut; extensor; γ-rigidity |
| UMN / LMN | Spastic, Babinski, hyperreflexia / flaccid, wasting, fasciculations |
| Cerebellum / basal ganglia | Hypotonia, intention tremor / Parkinson rigidity, resting tremor |
| Skeletal E–C | DHPR mechanically coupled to RyR1; troponin C |
Sense Organs
| Fact | Detail |
|---|---|
| Refraction | Cornea most; lens adjustable (accommodation: ciliary contraction, CN III) |
| Lenses | Myopia concave; hypermetropia convex; astigmatism cylindrical; P = 1/f |
| Rods | About 120 million; rhodopsin about 500 nm; scotopic; absent from fovea |
| Cones | About 6 million; S 420, M 530, L 560 nm; fovea |
| Phototransduction | Dark current via cGMP channels → light: R* → transducin → PDE6 → cGMP ↓ → hyperpolarisation |
| Recovery | Rhodopsin kinase, arrestin, RGS9, GCAPs (low Ca²⁺) |
| Visual cycle | RPE65 in RPE; vitamin A → night blindness if deficient |
| ON / OFF bipolars | mGluR6 (sign-inverting) / ionotropic |
| Pathway | Nasal fibres cross at chiasm; LGN 6 layers; V1 |
| Lesions | Chiasm → bitemporal hemianopia; tract → contralateral homonymous hemianopia |
| Pupillary reflex | Pretectal → Edinger–Westphal → CN III |
| Middle ear | Area ratio + lever; about 20× pressure gain |
| Endolymph | High K⁺ (about 150 mM), +80 mV (stria vascularis) |
| Tonotopy | Base high frequency; apex low |
| Hair cells | IHC sensory (most afferents); OHC prestin amplifier |
| Transduction | Tip links (cadherin-23, protocadherin-15) → K⁺ entry → depolarisation |
| Localisation | MSO time (low freq); LSO level (high freq) |
| dB | 20 log(P/P₀) |
| Weber / Rinne | Conductive: Weber to affected ear, Rinne negative; sensorineural: Weber to normal ear |
| Vestibular | Canals angular; utricle horizontal, saccule vertical linear |
| Touch | Meissner RA1; Pacinian RA2 vibration; Merkel SA1; Ruffini SA2; Piezo2 |
| Thermal | TRPV1 heat/capsaicin; TRPM8 cold/menthol (Nobel 2021) |
| Pain | Aδ fast; C slow; gate control |
Digestion and Energy Balance
| Fact | Detail |
|---|---|
| ENS | Myenteric (motility), submucosal (secretion); ICC slow waves |
| Parietal cell | HCl (H⁺/K⁺-ATPase), intrinsic factor; ACh, gastrin, histamine |
| Chief cell | Pepsinogen |
| Gastrin | G cells antrum; ↑ acid |
| CCK | I cells; fat, amino acids; enzymes, gallbladder, satiety |
| Secretin | S cells; acid; HCO₃⁻ (first hormone discovered; Bayliss and Starling 1902) |
| Incretins | GIP (K cells), GLP-1 (L cells) |
| Ghrelin / motilin / PYY | Hunger / MMC / satiety |
| Trypsinogen | Activated by enteropeptidase |
| Sugars | SGLT1 (glucose, galactose; Na⁺-coupled), GLUT5 (fructose), GLUT2 (exit) |
| Peptides | PepT1 (H⁺-coupled) |
| Fat | Lipase + colipase; micelles; chylomicrons (apoB-48) → lymph |
| B₁₂ | Haptocorrin → intrinsic factor → terminal ileum |
| Iron | Dcytb, DMT1, ferroportin; hepcidin blocks |
| Bile salts | 95% recycled from terminal ileum |
| TDEE | BMR (largest) + thermic effect of food (about 10%) + activity |
| RQ | Carbohydrate 1.0; protein 0.8; fat 0.7; lipogenesis above 1 |
| Weir | EE (kcal/min) = 3.941 VO₂ + 1.106 VCO₂ |
| O₂ equivalent | About 4.8 kcal/L O₂ |
| BMR conditions | Awake, supine, 12 h fast, thermoneutral, relaxed |
| BMR factors | Lean mass, thyroid hormone, age, sex, fever, pregnancy |
| Kleiber | Rate ∝ M^0.75; per gram ∝ M^−0.25 |
| Appetite | Leptin, insulin → POMC (α-MSH → MC4R) ↑, NPY/AgRP ↓; ghrelin → NPY/AgRP |
| ob/ob, db/db | No leptin / no leptin receptor |
Thermoregulation and Stress
| Fact | Detail |
|---|---|
| Heat balance | M − W ± R ± C ± K − E |
| Routes | Radiation largest at rest; only evaporation when air hotter than skin |
| Sweat | About 2.4 kJ/g evaporated; eccrine, sympathetic cholinergic |
| Thermostat | Preoptic anterior hypothalamus |
| Cold defence | Vasoconstriction, shivering, brown fat, piloerection, thyroid (slow) |
| Brown fat | NE → β₃ → cAMP → lipolysis → fatty acids activate UCP1 → heat |
| Thermoneutral zone | Minimal metabolic rate between lower and upper critical temperatures |
| Rules | Bergmann (larger in cold), Allen (shorter appendages in cold) |
| Fever | IL-1, IL-6, TNF-α → COX-2 → PGE₂ → EP3 → set point up |
| Hyperthermia | Set point normal; antipyretics useless |
| SAM axis | Adrenal medulla adrenaline; seconds |
| HPA axis | CRH → ACTH → cortisol; GR feedback (hippocampus too) |
| Cortisol | Gluconeogenesis, catabolism, anti-inflammatory, permissive; morning peak; induces PNMT |
| Selye | Alarm → resistance → exhaustion |
| Adaptation scales | Acclimation (lab, one factor), acclimatisation (natural), genetic adaptation (EPAS1 in Tibetans) |
| HIF | Prolyl hydroxylase + VHL degrade HIF-α in normoxia (Nobel 2019) |
Endocrinology and Reproduction
| Fact | Detail |
|---|---|
| Gs | Glucagon, ACTH, TSH, LH, FSH, PTH, ADH-V₂, β |
| Gq | GnRH, TRH, oxytocin, ADH-V₁, angiotensin II, α₁ |
| Gi | Somatostatin, α₂, D₂ |
| JAK–STAT | GH, prolactin, leptin, EPO |
| RTK | Insulin, IGF-1 |
| Nuclear | Steroids, T₃, calcitriol, retinoids |
| Hypothalamus | TRH, CRH, GnRH (pulsatile), GHRH, somatostatin, dopamine inhibits prolactin |
| Posterior pituitary | ADH, oxytocin made in SON/PVN |
| Stalk section | All anterior hormones fall except prolactin rises |
| Pineal | SCN → SCG → NE → AANAT → melatonin at night |
| Insects | PTTH → prothoracic glands → ecdysone (20E); corpora allata → JH; high JH larval, low pupal, none adult |
| Crustaceans | X-organ–sinus gland MIH; eyestalk ablation → moult |
| GH | Pulsatile; IGF-1; diabetogenic; Laron = receptor defect |
| Thyroid | NIS → pendrin → TPO (oxidation, organification, coupling); T₄ secreted, T₃ active; PTU, methimazole |
| Thyroid patterns | Primary hypo: TSH ↑ T₄ ↓; Graves: TSH ↓ T₄ ↑ |
| Calcium | PTH (Ca ↑, P ↓, 1α-hydroxylase ↑); calcitriol (Ca, P ↑); calcitonin (Ca ↓); FGF23 (P ↓, Klotho) |
| Adrenal cortex | Glomerulosa aldosterone (Ang II, K⁺); fasciculata cortisol (ACTH); reticularis androgens |
| Steroidogenesis | StAR, CYP11A1 rate-limiting; 21-OH deficiency → low cortisol and aldosterone, high 17-OH-progesterone, virilisation |
| Addison / Cushing / Conn | Low cortisol, high ACTH, pigment / cortisol excess / aldosterone excess, low renin |
| Medulla | Tyrosine hydroxylase (rate-limiting), DβH, PNMT (cortisol-induced) |
| β cell | Glucokinase → ATP/ADP ↑ → K_ATP (Kir6.2/SUR1) closes → Ca²⁺ → insulin |
| Insulin signalling | IRS → PI3K → Akt → GLUT4 |
| C-peptide | Endogenous insulin marker |
| Glucagon | Liver only (no muscle receptors) |
| Testis | Leydig: LH → testosterone; Sertoli: FSH → inhibin B, ABP, AMH, blood–testis barrier |
| Androgens | DHT (5α-reductase) external genitalia; estradiol (aromatase) bone, feedback |
| Ovary | Theca: LH → androgens; granulosa: FSH → aromatase → estradiol |
| Cycle | Estradiol positive feedback → LH surge → ovulation → corpus luteum progesterone → luteolysis |
| Oocyte arrests | Prophase I (diplotene) → metaphase II until fertilisation |
| Pregnancy | hCG (LH receptor) rescues corpus luteum; placenta takes over; estriol via fetoplacental unit; hPL anti-insulin |
| Parturition | Oxytocin + prostaglandins; Ferguson reflex |
| Lactation | Prolactin synthesis; oxytocin ejection; suckling suppresses GnRH |
| Sex differentiation | SRY → testis; AMH regresses Müllerian ducts; testosterone keeps Wolffian; DHT external |
| CAIS | 46,XY; female external genitalia; no uterus |
Microbiome, Interorgan Communication and Metabolic Disorders
| Fact | Detail |
|---|---|
| Holobiont | Host + microbes as a unit; hologenome |
| Gnotobiotic | All microbes known (germ-free or defined) |
| Model symbioses | Squid–Vibrio fischeri (light, quorum sensing); aphid–Buchnera (amino acids); Wolbachia (cytoplasmic incompatibility); rumen; corals |
| Gut density | About 10¹¹ cells per gram of colon content; strict anaerobes dominate |
| Bacteria : human cells | Same order of magnitude |
| Dominant phyla | Bacillota (Firmicutes), Bacteroidota (Bacteroidetes) |
| Infancy | Birth mode; milk oligosaccharides feed Bifidobacterium; adult-like by about 2–3 years |
| SCFAs | Acetate (most), propionate (liver gluconeogenesis), butyrate (colonocyte fuel, HDAC inhibitor, Tregs) |
| SCFA receptors | FFAR2 (GPR43), FFAR3 (GPR41) |
| Bile acids | Bacterial deconjugation and 7α-dehydroxylation; FXR → FGF19 → ↓ CYP7A1; TGR5 → GLP-1 |
| TMAO | Choline/carnitine → TMA (microbes) → TMAO (FMO3); associated with atherosclerosis |
| Germ-free mice | Enlarged caecum, weak gut immunity, lean and obesity-resistant, exaggerated HPA response, no secondary bile acids |
| Fat-harvest experiments | Conventionalisation ↑ fat without ↑ intake; obese-donor microbiota transfers more fat gain |
| Gut–brain routes | Vagus, endocrine, immune, metabolites; brain → gut via HPA and autonomic |
| Vagotomy control | Tests whether an effect needs the vagus |
| Dysbiosis | ↓ Diversity, ↓ butyrate producers, ↑ Proteobacteria, LPS endotoxaemia |
| FMT | Recurrent C. difficile |
| Pre / pro / syn / post-biotics | Substrate / live microbes / both / inactivated microbes or products |
| Shannon | H′ = −Σ p ln p; evenness = H′/ln S |
| Adipokines | Leptin ↑ and adiponectin ↓ in obesity |
| Myokines | IL-6; myostatin (GDF-8) limits muscle mass; irisin debated |
| Hepatokines | IGF-1, FGF21 (fasting, β-Klotho), fetuin-A |
| Loops | Cori (lactate), glucose–alanine, Randle, ketone bodies, enterohepatic |
| Sensors | AMPK (AMP/ATP, catabolic; inhibits ACC, mTORC1); mTORC1 (fed, anabolic); SIRT1 (NAD⁺) |
| Diabetes criteria | FPG ≥ 126 mg/dL (7.0 mM); 2-h OGTT ≥ 200 mg/dL (11.1 mM); HbA1c ≥ 6.5% |
| Type 1 | Autoimmune β-cell loss; insulin and C-peptide very low; DKA (high anion gap) |
| Type 2 | Insulin resistance (DAG–PKC, inflammation) + β-cell failure |
| MODY | Glucokinase, HNF1A; autosomal dominant |
| Drugs | Metformin (liver), GLP-1 agonists, DPP-4 inhibitors, SGLT2 inhibitors, TZDs (PPARγ), sulfonylureas (K_ATP) |
| HOMA-IR | Insulin (µU/mL) × glucose (mM) / 22.5 |
| BMI | kg/m²; ≥ 25 overweight, ≥ 30 obese (WHO) |
| Monogenic obesity | MC4R (commonest), leptin, LEPR, POMC |
| Metabolic syndrome | Central obesity, high TG, low HDL, high BP, high glucose (three of five, ATP III) |